Skip to main content
Donate
Login
Celebrate IASLC's 50th Anniversary
Celebrate IASLC's 50th Anniversary
History
Support The Mission
Support The Mission
Partners for Thoracic Cancer Care
Legacy Society
IASLC Global Member Survey on Inclusivity
Learn About Us
Learn About Us
Strategic Plan
Board of Directors
Committees
Awards
Staff
Contact
Search
Donate
Login
Conferences & Webinars
Conferences & Webinars
Upcoming Conferences & Webinars
Past Conferences & Webinars
WCLC 2024
Research & Education
Research & Education
Publications, Resources & Guidelines
Journals
Journals
Journal of Thoracic Oncology
JTO Clinical and Research Reports (JTO CRR)
IASLC Reviewer Workshop
Lung Cancer 360
Research Projects
Research Projects
Staging Project
IASLC Global Survey on Biomarker Testing in Lung Cancer 2024 Update
IASLC Neoadjuvant Therapy in Lung Cancers Initiatives
IASLC Atlas of Molecular Testing for Targeted Therapy in Lung Cancer
ELIC
Early-Career Opportunities
News
News
ILCN
Press Releases
Lung Cancer Considered Podcast
Membership
Membership
Become a Member
Renew Your Membership
Partner Society Membership Offers
Patient Advocacy
Patient Advocacy
STARS
Advocacy Partner Spotlight
Lung Cancer Awareness Month 2023 Highlights
Foundation
Foundation
Donor Recognition
Research Grant Program
Grant Recipient Spotlights
Research Grant Recipients
Search
Fulltext search
Fulltext search
Search
Displaying 37 - 48 items out of 334 results
ILCN article
Hereditary Predisposition Plays a Larger Role in SCLC Development Than Previously Recognized and May Inform Personalized Treatment
ILCN article
Promising Results for Lurbinectedin in SCLC When Paired with Irinotecan
ILCN article
More Options Needed After First-Line Chemoimmunotherapy in Lung Cancer
ILCN article
Statistical Design Flexibility Versus Optimism: The Example of KEYNOTE-604
ILCN article
SBRT Versus Surgery in the COVID-19 Era: What Has Changed and What Hasn't?
ILCN article
Questions Remain Following Long-Term Results of the Phase II SABR-COMET Trial
ILCN article
The Immune System: A New Organ at Risk in Lung Cancer Radiation Therapy?
ILCN article
Understanding the Promising Role of Stereotactic Ablative Radiotherapy in Treating Patients With Oligometastatic Disease
ILCN article
University of California, Davis, Thoracic Oncology Innovation Group to Again Host Latin American Oncologists for 3-Day Preceptorship
ILCN article
Cardiac Radiation Dose, Cardiac Events, and Survival in Locally Advanced NSCLC
ILCN article
Cell-free RNA Affords Another Tool in Lung Cancer Diagnosis and Treatment Monitoring
ILCN article
Supporting the Detection of Early-Stage Disease with Use of Biomarkers
Pagination
First
First page
‹
Previous page
1
2
3
4
5
6
7
8
9
…
›
Next page
Last
Last page